Cardinal Health price target raised to $133 from $117 at Barclays

Barclays analyst Stephanie Davis raised the firm’s price target on Cardinal Health (CAH) to $133 from $117 and keeps an Overweight rating on the shares. The company reported a strong fisacal Q1 print that cleared the high bar, the analyst tells investors in a research note. The firm remains bullish on Cardinal’s core distribution in the current macro tape and is positive on the company’s recent execution proof points.